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OligomerizationDaptomycin is a lipopeptide antibiotic that binds to and depolarizes bacterial cell membranes. Its antibacter-
ial activity requires calcium and correlates with the content of phosphatidylglycerol in the target membrane.
Daptomycin has been shown to form oligomers on liposomemembranes. We here use perylene excimer ﬂuo-
rescence to further characterize the membrane-associated oligomer. To this end, the N-terminal fatty acyl
chain was replaced with perylene-butanoic acid. The perylene derivative retains one third of the antibacterial
activity of native daptomycin. On liposomes containing phosphatidylcholine and phosphatidylglycerol, as
well as on Bacillus subtilis cells, the perylene-labeled daptomycin forms excimers, which shows that the N-
terminal acyl chains of neighboring oligomer subunits are in immediate contact with one another. In a
lipid bicelle system, oligomer formation can be titrated with stoichiometric amounts of phosphatidylglycerol.
Therefore, the interaction of daptomycin with a single molecule of phosphatidylglycerol is sufﬁcient to trig-
ger daptomycin oligomerization.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Daptomycin is a cyclic lipopeptide that consists of 13 amino acid
residues, including one kynurenine residue and several other non-
standard amino acids, and a decanoyl fatty acyl residue attached to
the exocyclic N-terminal tryptophan residue (see Fig. 1). It is pro-
duced by the soil bacterium Streptomyces roseosporus. Daptomycin is
used in the treatment of infections by Gram-positive bacteria such
as enterococci and staphylococci, including strains that are resistant
to penicillin, methicillin and vancomycin [1,2]. Daptomycin binds
and depolarizes the bacterial cytoplasmic membrane [3]. Its activity
requires calcium and correlates with the target membrane's content
of phosphatidylglycerol (PG); increased conversion of PG to lysyl-
PG confers partial resistance to bacterial cells [4,5].
Using FRET between the kynurenine residue of unlabeled dapto-
mycin and a ﬂuorescently labeled derivative of daptomycin, we
have shown before that daptomycin forms oligomers on liposome
membranes [6]. Oligomerization occurs under conditions that resem-
ble those required for its antibacterial activity, suggesting that the
oligomer is involved in the bactericidal effect.
In this study, we have used excimer ﬂuorescence in order to further
characterize the membrane-associated daptomycin oligomer. An exci-
mer, or excited dimer, is a complex that forms from one ﬂuorophore
molecule that is in the excited state and another one in the ground.
rights reserved.state [7]. Since this requires direct contact between two ﬂuorophore
molecules, the detection of excimer ﬂuorescence imposes a more strin-
gent constraint on the distance of the interaction than that implied by
the observation of FRET.
The ﬂuorophore most widely used to study excimer ﬂuorescence
is pyrene, whose excimer and monomer spectra are well separated.
However, when pyrene was incorporated into daptomycin, we ob-
served that most pyrene ﬂuorescence was lost due to energy transfer
to kynurenine. We therefore chose to incorporate perylene, which
emits at longer wavelengths [8] and therefore should not engage in
FRET to kynurenine.
A prior study has shown that substitutions of the N-terminal
decanoyl moiety of daptomycin are quite compatible with its antibac-
terial activity, as long as the introduced substituents retain an overall
hydrophobic character [9]. Pyrene and perylene are very hydrophobic
molecules, and accordingly they were introduced into daptomycin by
replacing the decanoyl chain with pyrenebutanoic acid and perylene-
butanoic acid, respectively. The derivatives retained antibacterial activ-
ity, albeit at a slightly reduced level in the case of perylene-daptomycin.
Nevertheless, oligomer formation of perylene-daptomycin was clearly
evident through excimer ﬂuorescence, under conditions that mirrored
those used in the previous FRET experiments. This result indicates
that the fatty acyl residues of adjacent subunits of the membrane-
associated daptomycin oligomer are within immediate reach of one
another.
In a lipid bicelle system, the excimer ﬂuorescence could be titrated
with phosphatidylglycerol. Conversion of monomer ﬂuorescence to
excimer ﬂuorescence approached saturation at an equimolar ratio of
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Fig. 1. Structure of daptomycin, and of the substituents pyrene- and perylene-butanoic acid that was substituted for the decanoyl residue of the native compound in this study.
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phosphatidylglycerol is sufﬁcient to convert daptomycin to a confor-
mation that is competent for oligomerization.
Our study provides signiﬁcant additional insight into the process
of daptomycin oligomerization. At the same time, it demonstrates
that perylene excimer ﬂuorescence is useful as a probe in the experi-
mental study of biochemical systems.
2. Materials and methods
2.1. Synthesis of perylene-daptomycin
To a suspension of deacylated daptomycin bearing a Boc protect-
ing group on the ornithine residue (120 mg, 0.077 mmol; generously
provided by Jared Silverman of Cubist Inc.) in dry dimethylformamide
(0.5 mL) was added 4-(3-perylenyl)butanoic acid succinimidyl ester
(see supporting information; 0.035 g, 0.08 mmol). The mixture was
stirred for 24 h and then concentrated by high vacuum rotary evapo-
ration. The residue was dissolved in water and lyophilized. The lyoph-
ilized powder was dissolved in an ice cold solution of triﬂuoroacetic
acid (TFA) containing 2% thioanisole, and the resulting solution was
stirred for 15 min at 0 °C (ice bath). The mixture was concentrated
using a high vacuum rotary evaporator, keeping the heating bath
below 40 °C. The residue was dissolved in water and lyophilized.
The resulting crude powder was puriﬁed by semi-preparative re-
versed-phase HPLC employing a linear gradient starting with 95%
water (0.1% TFA)–5% acetonitrile to 100% acetonitrile over 50 minutes
(tr=34 min). Fractions containing the desired product were pooled
and concentrated using a high vacuum rotary evaporator keeping
the heating bath below 40 °C. The resulting residue was lyophilized
to give 0.047 g (34% yield) of perylene-daptomycin as a yellowpowder.
−ESIMS: 1784.76 (M−H)−1 (Fig. S1). The analytical reversed-phase
HPLC chromatogram of the puriﬁed material, using a linear gradient
starting with 95% water (0.1% TFA)–5% acetonitrile to 100% acetonitrile
over 50 min is shown in Fig. S2.
2.2. Synthesis of pyrene-daptomycin
This compound was prepared using the same procedure as that
described above for perylene-daptomycin using 0.0081 g (0.021 mmol)
1-pyrenebutanoic acid succinimidyl ester and 0.030 g (0.019 mmol)
deacylated daptomycin bearing a Boc protecting group on the ornithine
residue. The crude product was puriﬁed by HPLC as described above for
perylene-daptomycin (tr=28 min). Fractions containing the desiredproduct were pooled and concentrated and the resulting residue lyoph-
ilized to give 17 mg (51% yield) of pyrene-daptomycin as a white pow-
der. -ESIMS: 1734.75 (M−H)−1 (Fig. S3). The analytical reversed-
phase HPLC chromatogram of the puriﬁed material using the conditions
described above for perylene-daptomycin is shown in Fig. S4.
2.3. Antibacterial activity test for pyrene- and perylene-daptomycin
The two labeled derivatives as well as native daptomycin were
tested for antibacterial activity by broth dilution. LB broth was sup-
plemented with calcium (5 mM), and the daptomycin derivative in
question was added at concentrations of 10, 5, 3, 2, 1.5, and 1 μg/ml.
Each tube was inoculated with Bacillus subtilis ATCC 1046 and incu-
bated overnight at 37 °C. Growth inhibition was evaluated visually
by turbidity. Growth controls without antibiotic were prepared for
comparison.
2.4. Preparation of large unilamellar vesicles (LUV)
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-
dimyristoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] (DMPG), 1-
palmitoyl-2-oleoyl-sn-glycerol-3-phosphoethanol (POPE), 1,2-
dioleoyl-sn-glycerol-3-phospho-(1-rac-glycerol) (DOPG), and 1,3-bis
[1,2-dioleoyl-sn-glycero-3-phospho]-sn-glycerol (tetra-oleyl-cardiolipin;
TOCL) were purchased from Avanti Polar Lipids, Inc. (Alabaster, AL,
USA). The required amounts of DMPC and DMPG, or of POPE, DOPG and
cardiolipin, were weighted, dissolved in chloroform and transferred to a
round-bottom ﬂask. The solvent was evaporated with nitrogen and the
resulting lipidﬁlms further driedunder vacuumfor three hours. The lipids
were then suspended in HEPES 20 mM, pH 7.4, NaCl 150 mM (HBS).
Finally, the suspension was extruded 10–15 times through 100 nm poly-
carbonate ﬁlters, using a nitrogen-pressurized extrusion device [10]. The
liposomeswere employed in the ﬂuorescence experiments at a ﬁnal con-
centration of 250 μM total lipid.
2.5. Fluorescence measurements
Emission spectra were acquired on a QuantaMaster 4 spectroﬂuo-
rimeter (Photon Technology International, London, ON). Pyrene ﬂuo-
rescence was excited at 340 nm and the emission recorded from 360
to 600 nm. Perylene ﬂuorescence was excited at 430 nm and the
emission recorded from 440 to 600 nm. Bandpasses for excitation
and emission were between 2 and 5 nm, depending on the sample
concentration. Emission spectra were corrected for wavelength-
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Fig. 2. Fluorescence emission spectra of pyrene-daptomycin in solution and on DMPC/
DMPG liposomes, in the presence of 6 mM calcium. The excitation wavelength was
340 nm.
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a tabulated normalized quinine spectrum listed in Ref. [7].
Fluorescence lifetimemeasurements were performed on a FluoTime
100 Lifetime spectrometer (PicoQuant, Berlin, Germany), using diode
laser light sources emitting at 370 nm and at 440 nm for pyrene and
perylene, respectively. The emission was isolated using 460±10 nm
or 560±10 nm bandpass ﬁlters (Melles-Griot, Brossard, QC). Experi-
mental decays were numerically ﬁtted with two or three exponentials,
with resulting χ2 values typically between 1.1 and 1.3. From these ﬁtted
exponential components, average lifetimes were calculated according
to the equation
τ ¼∑αiτ
2
i
∑αiτi
were αi represents the amplitude at time zero and τi the lifetime of the
ith component.
All measurements were acquired at room temperature. The con-
centration of calcium was 200 mM with liposomes consisting of PC
only. With all other samples, the calcium concentration was 5 mM
unless stated otherwise.
2.6. Deconvolution of perylene excimer and monomer spectra
Perylene ﬂuorescence decays were measured at 560±10 nm on
DMPC/DMPG membranes, both with pure perylene-daptomycin and
with a mixture of perylene-daptomycin and a ﬁvefold excess of unla-
beled daptomycin. The decays were ﬁtted to a two-exponential
model. The fractional emission intensities of the monomer and the
excimer at 560 nm were obtained from these data according to
Fmonomer;560 ¼
α1τ1
α1τ1 þ α2τ2
and Fexcimer;560 ¼ 1−Fmonomer;560
From the spectrum of perylene-daptomycin only, P, and the spec-
trum of the mixture of perylene-daptomycin with unlabeled dapto-
mycin, U, the pure excimer spectrum, E, was calculated as
E ¼ P−aU
with
a ¼ FP;monomer;560IP;560
FU;monomer;560IU;560
where IP, 560and IU, 560 denote the intensity of P and U at 560 nm, re-
spectively. The pure monomer spectrumMwas obtained analogously.
After normalizing E and M to the same quantity of molecules, the
quantum yield of the excimer, relative to that of the monomer, was
calculated from the ratio of the areas of the two normalized spectra.
2.7. Titration of perylene excimer ﬂuorescence with phosphatidylglycerol
To a solution of 100 μM perylene-daptomycin, 1 mM Ca++ and
20 mM DHPC in HBS, a mixture of DMPC and DMPG (molar ratio,
4:1) was added in a stepwise fashion. After each addition, the mixture
was incubated for 2 min before acquisition of the perylene emission
spectrum. Repeated scans showed that this short incubation sufﬁced
to reach equilibrium. From each spectrum, the ratio of the emission
intensities at 521 nm and 480 nm was calculated, and the increment
was plotted as a function of the molar ratio of DMPG to perylene-
daptomycin.3. Results
3.1. Synthesis and puriﬁcation of pyrene- and perylene-daptomcyin
The synthetic procedure, as well as mass spectrometry and chro-
matography data on the product are given in the supplementary in-
formation ﬁle. The structures of pyrene- and perylene-daptomycin
are shown in Fig. 1.
3.2. Antibacterial activity of pyrene- and perylene-daptomycin
The antibacterial activity of pyrene- and perylene-daptomycin
against B. subtilis strain ATCC 1046 was determined by broth dilution,
using native daptomycin as a reference. The minimum inhibitory con-
centration of perylene-daptomycin was 3 μg/ml, compared to 1 μg/ml
for native daptomycin and pyrene-daptomycin. Therefore, the speciﬁc
activity of perylene-daptomycin is approximately 3 times lower than
that of native daptomycin and of pyrene-daptomycin.
3.3. Fluorescence of pyrene-daptomycin
Fig. 2 shows the emission spectra of pyrene-daptomycin in solu-
tion and on liposomes consisting of phosphatidylcholine (PC) and
phosphatidylglycerol (PG). Pyrene monomer ﬂuorescence, which is
apparent in the small peaks to both sides of 380 nm, is very low in
both samples. There is a broad peak around 460 nm that greatly in-
creases after incubation with the liposomes, on which daptomycin
has been shown to form oligomers.
While oligomer formation should be accompanied by excimer for-
mation, the latter should be accompanied by a decrease of monomer
emission, which however is low to begin with and does not decrease
any further. Furthermore, the peak at 460 nm has an average excited
state lifetime of approximately 3.5 ns (data not shown), whereas the
typical lifetimes of pyrene excimers are much longer. On the other
hand, the observed lifetime is very similar to that found previously
for the kynurenine residue of daptomycin [6].
The monomer emission spectrum of pyrene signiﬁcantly overlaps the
absorption spectrum of the kynurenine residue, which should cause ﬂuo-
rescence energy transfer from excited pyrene to kynurenine. The increase
in the sensitized kynurenine emission upon membrane binding mirrors
that of directly excited kynurenine ﬂuorescence reported earlier [11].
In sum, because of spectral overlap between pyrene emission and
kynurenine absorption, pyrene-daptomycin does not produce exper-
imentally useful excimer ﬂuorescence.
3.4. Observation of perylene-daptomycin excimer ﬂuorescence
The emission spectrum of perylene-daptomycin in solution re-
sembles that of monomeric, free perylene in hexane [8], with three
676 J.K. Muraih et al. / Biochimica et Biophysica Acta 1818 (2012) 673–678distinct peaks between 450 and 520 nm (Fig. 3A). A similar spectrum
is obtained when perylene-daptomycin is incubated with DMPC
membranes (Fig. 3B). In contrast, on membranes composed of
DMPC and DMPG, as well as on bacterial cells, the shape of the spec-
trum changes signiﬁcantly (Fig. 3C, D). The two leftmost peaks are
greatly decreased, and a new, broad peak emerges that overlaps the
monomer ﬂuorescence. While the new peak is centered around
525 nm and therefore is blue-shifted relative to the excimer of free
perylene [8], its shape nevertheless is suggestive of excimer ﬂuores-
cence. This interpretation is corroborated by time-resolved ﬂuores-
cence measurements. Fig. 4 shows the ﬂuorescence decays measured
at 560 nm of perylene-daptomycin on PC liposomes (A) and on PC/PG
liposomes (B). Both decays can be ﬁtted quite well with a two-
exponential model (see ﬁt parameter values in the ﬁgure), and the life-
time parameters obtained from these ﬁts are similar to those of pery-
lene monomers and excimers reported earlier [8]. Note that the
pre-exponentials are different between the two membranes, which
reﬂects a higher prevalence of excimers on the PC/PG membranes.
Also, the ﬁttedﬂuorescence lifetime of the putative excimer component
is shorter in PC than in PC/PG membranes.
Excimer ﬂuorescence only occurs when a monomer in the excited
state binds directly to a another monomer that is in the ground state.
It should therefore be greatly facilitated by the formation of stable
oligomers, since within these the perylene moieties should remain
close to one another throughout. On the other hand, a mixture of
perylene-daptomycin with an excess of unlabeled daptomycin should
produce hybrid oligomers, within which the perylene-labeled mole-
cules should become separated from one another by intervening
unlabeled molecules. This should lead to increased monomer ﬂuores-
cence and decreased excimer ﬂuorescence. Fig. 5 shows that this is
indeed the case. It also shows that, on PC membranes, the ratio of
excimer ﬂuorescence to monomer ﬂuorescence is not affected by 0
 100
 200
 300  400  500  600
 0
 1
 2
Em
is
si
on
 (c
ps
/10
00
)
O
pt
ica
l D
en
sit
y
Wavelength (nm)
 0
 25
 50
 75
 100
 440  480  520  560  600
Em
is
si
on
 (c
ps
/10
,00
0)
Wavelength (nm)
OD (PD)
OD (ND)
PC/PG 250 μM, Ca++ 6 mM
A
Emission (PD)
C
Fig. 3. Fluorescence emission spectra of perylene-daptomycin, in solution (A), on DMPC lipos
tra were measured with 2.5 μM perylene-daptomycin. In (A), the absorption spectra of pe
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then washed twice by centrifugation to remove unbound daptomycin and resuspended befthe addition of unlabeled daptomycin. This is in line with the assump-
tion that stable oligomers do not form on these membranes, and that
excimer ﬂuorescence arises by diffusional collision of individual
perylene-daptomycin molecules only.
Very similar spectra and ﬂuorescence lifetimes were obtained on
liposomes consisting of POPE, DOPG and TOCL, which are considered
models of the cytoplasmic membranes of bacteria [12,13]. This is in
line with prior observations [6].
3.5. Quantitative evaluation of excimer ﬂuorescence
By combining lifetime data with steady state spectra, we can ob-
tain an approximation of the spectrum of the excimer, as well as an
estimate of its quantum yield relative to that of the monomer. The
calculation, which is detailed in the To xml; gs1 section, yields the
monomer and excimer spectra shown in Fig. 6. The quantum yield
of the excimer, relative to that of the monomer, is 0.35.
On PC/PG membranes, the observed excimer emission corre-
sponds to >90% of all excitation events. If we neglect excimer emis-
sion due to collisional encounters of the few remaining monomers,
we can infer that more than 90% of all daptomycin molecules are
now located in oligomers. Considering that some excited perylene
molecules will emit monomer ﬂuorescence even when placed in the
vicinity of other perylene molecules, the extent of oligomer formation
may well be even higher.
At an oligomerization efﬁciency of 90%, the ratio of emission at
521 nm to that at 482 nm is 1.35 (Fig. 3C). This ratio is 0.33 for PC li-
posomes (Fig. 3B), on which perylene-daptomycin emits mostly as a
monomer. On bacterial cells (Fig. 3D), it is 1.16, which shows that
most of the cell-bound perylene-daptomycin have become incorpo-
rated into oligomers. Therefore, on suitable membranes, oligomeriza-
tion of daptomycin approaches or reaches completion. 0
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In previous studies [6,11,14], phosphatidylglycerol was used in
considerable molar excess over daptomycin, and therefore these ex-
periments did not provide information on the stoichiometry of the in-
teraction of daptomycin with PG. To examine this question, we used a 0.25
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Fig. 5. Effect of unlabeled daptomyin on the extent of excimer formation by perylene-
daptomycin. Perylene-daptomycin (2.5 μM) was mixed with unlabeled daptomycin at
the molar ratios indicated and incubated with DMPG/DMPC or DMPC liposomes with 6
and 200 mM of calcium, respectively. The change in ﬂuorescence is represented the
ratio of emission at 521 nm over that at 482 nm; a higher ratio indicates a greater ex-
tent of excimer formation.mixture of DMPC and DMPG with an excess of dihexanoyl-PC. Mix-
tures of the latter with lipids of typical acyl chain length yield lipid
bicelles, which are small, disk-like lipid aggregates that are suitable
as membrane mimetics [15]. The advantage of bicelles over liposomes
is twofold. Firstly, suspensions of bicelles aremuch less turbid. This allows
measurements at higher concentrations of daptomycin and PG, which
will help to drive the reaction between the two toward completion. Sec-
ondly, in a bicelle, both monolayers will be exposed to daptomycin. In
contrast, with liposomes, only the outer monolayer may be accessible.
Previous observation of membrane fusion induced by daptomycin in
model liposomes [14] suggests that themembrane continuitymay be dis-
rupted, and bothmonolayersmay be accessible to daptomycin in this sys-
tem also. On the other hand, membrane fusion did not go to completion.
In addition, no morphological changes to the cell membranes of
daptomycin-treated bacteria were observed by electron microscopy
[16], suggesting that the inner monolayer may be not or only incom-
pletely accessible to daptomycin. Use of bicelles avoids this uncertainty.
Fig. 7 shows the titration of 100 μMperylene-daptomycin, in 20 mM
dihexanoyl-PC and 1 mMcalcium,with amixture of dimyristoyl-PC and
dimyristoyl-PG. Excimer formation is monitored as the ratio of ﬂuores-
cence intensities at wavelengths 521 nm and 482 nm. It can be seen
that the extent of excimer formation, and thus oligomerization, ap-
proaches saturation after addition of a stoichiometric amount of
phosphatidylglycerol.
4. Discussion
In this study, we synthesized pyrene-daptomycin and perylene-
daptomcyin and used the latter to characterize the oligomerization 0
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tangents of the ﬁt curve at zero and inﬁnity, respectively.
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into daptomycin by substituting it for the normal decanoyl chain.
Considering the substantial bulk that is added to the molecule by
this modiﬁcation, the fact that the antimicrobial activity is reduced
no more than threefold is quite remarkable, as is the observation
that the introduction of pyrene caused no measurable decrease in ac-
tivity at all. These observations are, however, in line with a previous
study on a variety of acyl analogues, which revealed only minor
changes to the antibacterial activity, as long as the overall hydropho-
bic character of the acyl chain was preserved [9]. While the spectral
overlap between pyrene and kynurenine prevented the observation
of pyrene excimer ﬂuorescence, excimers could be observed and
used to characterize the oligomerization of daptomycin.
The perylene excimer ﬂuorescence indicated the formation of
daptomycin oligomers on both liposomes and bacterial cells. In lipo-
somes, oligomerization correlates with the presence of phosphatidyl-
glycerol. These ﬁndings are entirely consistent with those of a
previous study that used ﬂuorescence energy transfer [6]. Beyond
this conﬁrmation, the use of perylene-daptomcyin provides signiﬁ-
cant additional insights that could not be inferred from previous
experiments.
The ﬁrst novel observation is the formation of daptomycin oligo-
mers on live bacterial cells. Secondly, using perylene-daptomcyin,
the extent of oligomerization could be measured. This extent exceeds
90% on model membranes that contain 50% DMPG, and it is only
slightly lower on bacterial membranes. This high extent of oligomer-
ization supports the notion that it is the oligomer that causes the bac-
tericidal effect.
Thirdly, the formation of perylene excimers shows that, in the
oligomer, the N-terminal acyl chains interact directly with one another.
Direct interaction of the daptomycin peptide moieties within the oligo-
merwas previously inferred from the self-quenching of NBD-labels that
had been attached to their ornithine residues [6]. Taken together, these
two points of mutual interaction suggest that neighboring oligomer
subunits are aligned in a parallel fashion, or form an acute angle with
one another.
The fourth novel ﬁnding reported here is that daptomycin oligo-
merization is driven by a stoichiometric interaction with phosphati-
dylglycerol. This result suggests that PG interacts with daptomycin
directly and speciﬁcally, rather than indirectly through inﬂuencing
bulk properties of the membrane such as charge or lateral phase seg-
regation. Enhanced conversion of PG to lysyl-PG by bacterial cells has
been reported as a mechanism of partial resistance to daptomycin
[4,5], which supports the notion that PG-mediated oligomerization
is essential for the activity of daptomycin.
In summary, the current study provides signiﬁcant new insights
into the interaction of daptomycin with itself and with membrane
lipids. At the same time, this study is the ﬁrst one to use perylene
excimer ﬂuorescence for the characterization of peptide or protein
oligomerization. The results provided here illustrate that perylene
should be a valuable tool wherever the occurrence of intrinsicchromophores or ﬂuorophores precludes the use of pyrene-labeled
probes.
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